Aptinyx Inc reported $-19379000 in Operating Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -33.65M 79.36M
Acorda Therapeutics ACOR:US $ -13.92M 2.79M
Biogen BIIB:US $ -59.1M 669.8M
Cara Therapeutics CARA:US $ -4472000 23.44M
Daiichi Sankyo 4568:JP Y 34382M 85129M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Halozyme Therapeutics HALO:US $ 34.06M 41.61M
Intra Cellular Therapies ITCI:US $ -87.92M 15.26M
IONIS PHARMACEUT IONS:US $ -85.51M 28.01M
Marinus Pharmaceuticals MRNS:US $ -36.77M 20.06M
Neurocrine Biosciences NBIX:US $ -15.3M 18.4M
Novartis NOVN:VX 2.23B 624M
Ultragenyx Pharmaceutical RARE:US $ -141.59M 4.96M
Vertex Pharmaceuticals VRTX:US $ 1106.3M 65.4M